SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055843
Filing Date
2021-11-10
Accepted
2021-11-09 18:15:37
Documents
77
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-10q_20210930.htm   iXBRL 10-Q 3969974
2 EX-10.2 stro-ex102_195.htm EX-10.2 81048
3 EX-31.1 stro-ex311_9.htm EX-31.1 17667
4 EX-31.2 stro-ex312_10.htm EX-31.2 16901
5 EX-32.1 stro-ex321_8.htm EX-32.1 6614
6 EX-32.2 stro-ex322_6.htm EX-32.2 6644
  Complete submission text file 0001564590-21-055843.txt   12801645

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA stro-20210930.xsd EX-101.SCH 73942
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stro-20210930_cal.xml EX-101.CAL 55071
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stro-20210930_def.xml EX-101.DEF 275127
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20210930_lab.xml EX-101.LAB 541543
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20210930_pre.xml EX-101.PRE 434576
12 EXTRACTED XBRL INSTANCE DOCUMENT stro-10q_20210930_htm.xml XML 2527703
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 211393633
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences